PharmaCyte Biotech Inc (PMCB)
2.155
-0.02
(-0.99%)
USD |
NASDAQ |
May 10, 16:00
2.16
0.00 (0.00%)
After-Hours: 20:00
PharmaCyte Biotech EPS Diluted (Quarterly): -0.65 for Jan. 31, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -0.65 |
| October 31, 2023 | -0.26 |
| July 31, 2023 | -0.28 |
| April 30, 2023 | -0.01 |
| January 31, 2023 | -0.04 |
| October 31, 2022 | -0.09 |
| July 31, 2022 | -0.07 |
| April 30, 2022 | -0.06 |
| January 31, 2022 | -0.04 |
| October 31, 2021 | -0.06 |
| July 31, 2021 | -0.64 |
| April 30, 2021 | -0.61 |
| January 31, 2021 | -0.49 |
| October 31, 2020 | -0.62 |
| July 31, 2020 | -0.79 |
| April 30, 2020 | -0.6385 |
| January 31, 2020 | -0.9541 |
| October 31, 2019 | -1.207 |
| July 31, 2019 | -1.405 |
| April 30, 2019 | -1.493 |
| January 31, 2019 | -0.8998 |
| October 31, 2018 | -1.438 |
| July 31, 2018 | -1.741 |
| April 30, 2018 | 0.00 |
| January 31, 2018 | -3.120 |
| Date | Value |
|---|---|
| October 31, 2017 | -2.795 |
| July 31, 2017 | -2.735 |
| April 30, 2017 | -9.068 |
| January 31, 2017 | -2.236 |
| October 31, 2016 | -1.721 |
| July 31, 2016 | -1.963 |
| April 30, 2016 | 0.00 |
| January 31, 2016 | -3.549 |
| October 31, 2015 | -3.290 |
| July 31, 2015 | -3.078 |
| April 30, 2015 | 0.00 |
| January 31, 2015 | -3.140 |
| October 31, 2014 | -14.99 |
| July 31, 2014 | -3.385 |
| April 30, 2014 | -44.98 |
| January 31, 2014 | -1.146 |
| October 31, 2013 | -14.99 |
| July 31, 2013 | -14.99 |
| April 30, 2013 | -1.033 |
| January 31, 2013 | -1.270 |
| October 31, 2012 | -1.336 |
| July 31, 2012 | -1.824 |
| April 30, 2012 | -9.368 |
| January 31, 2012 | -1.091 |
| October 31, 2011 | 0.00 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-1.405
Minimum
Jul 2019
-0.01
Maximum
Apr 2023
-0.4692
Average
-0.49
Median
Jan 2021
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp | -0.14 |
| AIM ImmunoTech Inc | -0.26 |
| IGC Pharma Inc | -0.09 |
| NovaBay Pharmaceuticals Inc | -0.8165 |
| Protalix BioTherapeutics Inc | -0.10 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.6195M |
| Total Expenses (Quarterly) | 1.869M |
| Enterprise Value | -25.45M |
| Earnings Yield | -55.68% |
| Normalized Earnings Yield | -701.32 |